+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID04974671

Phase II Study of Stereotactic Body Radiation Therapy for Metastatic Renal Cell Carcinoma with Oligoprogression on Immune Checkpoint Inhibitors

Led by Yale University · Updated on 2025-12-04

30

Participants Needed

1

Research Sites

65 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating progression-free survival in patients with metastatic renal cell carcinoma who have limited progression 1-5 lesions while on immune checkpoint inhibitor-containing treatments. This Phase II trial focuses on patients who received their last systemic therapy dose within 3 months before joining the study. The study allows alternative local therapies to some lesions, but at least one lesion must be treated with Stereotactic Body Radiation Therapy SBRT. Participants will receive SBRT, delivering 1 to 5 fractions on nonconsecutive days depending on the lesion location, as decided by their treating physician. Treatment to multiple sites may be done at the same time or one after another. Patients will continue their immune checkpoint inhibitor regimen during and after SBRT unless disease progression occurs. A multidisciplinary tumor board will review each case before enrollment. During the study, participants will have imaging tests such as CT scans, PET CT, or MRI to assess treatment response using RECIST criteria. Researchers will monitor side effects and toxicities both short and long term. The main outcome is progression-free survival at 6 months, with additional measures of recurrence, response rates, and overall survival tracked up to two years. Patients will be followed regularly to evaluate their health and treatment effects throughout the study period.

CONDITIONS

Brief Title

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Research Team

P

Patricia Brand

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here